Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ratech

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
American Journal of Clinical Pathology|December 1, 1982
Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancerD F Roses, D A Bell, T J Flotte, et al.
Transplantation|June 28, 2003
Primary intestinal posttransplant T-cell lymphomaJ Michael, S Greenstein, R Schechner, et al.
Transplantation|August 1, 1987
Epstein-Barr-virus-related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemiaS J Forman, J L Sullivan, C Wright, et al.
Medical Oncology (Northwood, London, England)|June 27, 1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Medical Oncology (Northwood, London, England)|December 1, 1996
Atypical clonal T-cell proliferation in infectious mononucleosisU R Malik, L Oleksowicz, J P Dutcher, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
Non-Hodgkin's lymphoma in women with breast cancerP H Wiernik, X Hu, H Ratech, et al.
Immunity|July 1, 1994
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient miceM L Arbonés, D C Ord, K Ley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
American Journal of Clinical Pathology|December 1, 1982
Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancerD F Roses, D A Bell, T J Flotte, et al.
Transplantation|June 28, 2003
Primary intestinal posttransplant T-cell lymphomaJ Michael, S Greenstein, R Schechner, et al.
Transplantation|August 1, 1987
Epstein-Barr-virus-related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemiaS J Forman, J L Sullivan, C Wright, et al.
Medical Oncology (Northwood, London, England)|June 27, 1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Medical Oncology (Northwood, London, England)|December 1, 1996
Atypical clonal T-cell proliferation in infectious mononucleosisU R Malik, L Oleksowicz, J P Dutcher, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
Non-Hodgkin's lymphoma in women with breast cancerP H Wiernik, X Hu, H Ratech, et al.
Immunity|July 1, 1994
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient miceM L Arbonés, D C Ord, K Ley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Pageof 5